Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Montanova Capital, LLC reported a 6.30% stake in Fulcrum Therapeutics, Inc. (Schedule 13G)
Event Dec 27, 2024 · Filed Jan 6, 2025
Montanova Capital, LLC reported a 6.30% stake in Fulcrum Therapeutics, Inc., 3,404,612 shares, as a passive investor on Dec 27, 2024. Filed Jan 6, 2025 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 3,404,612
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.30% | 3,404,612 |
| Averill Master Fund, Ltd. | 5.80% | 3,151,741 |
| Aaron Cowen | 6.30% | 3,404,612 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Montanova Capital, LLC
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · May 2, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026